Kenji Sugio - Concepedia

Author

Kenji Sugio

Kyushu University ORCID

Also Known As

K SUGIO, K Sugio, K. Sugio, KENJI SUGIO, Kenji SUGIO, Kenji Sugio, S. Kenji, Sugio Kenji, T Sakada, Tomoko So

391

Publications

9.1K

Citations

H-Index

127

Concepts

All Affiliations

Kyushu University University of Occupational and Environmental Health Japan Oita University National Hospital Organization Kyushu Cancer Center Kyushu University Hospital

About

Kenji Sugio is an author at Kyushu University specializing in medicine, lung cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	41	111	5.2K
2	Health Sciences	15	21	863
3	Public Health	4	4	131
4	Engineering	1	1	17
5	Allergy	1	1	53

Kenji Sugio

177

Publications

8.4K

Citations

H-Index

Page 1

	Year	Citations
Smoke exposure, histologic type and geography‐related differences in the methylation profiles of non‐small cell lung cancer Shinichi Toyooka, Riichiroh Maruyama, Kiyomi O. Toyooka, International Journal of Cancer	2002	287
DNA methylation profiles of lung tumors. Shinichi Toyooka, Kiyomi O. Toyooka, Riichiroh Maruyama, PubMed Epigenetic ChangeDna MethylationPathologyNsclc TumorsEpigenetics	2001	231
Allele-Specific Loss in Chromosome 9p Loci in Preneoplastic Lesions Accompanying Non-Small-Cell Lung Cancers Yui Kishimoto, Kenji Sugio, Jen‐Yu Hung, JNCI Journal of the National Cancer Institute	1995	209
Expression of E-cadherin and beta-catenin in human non-small cell lung cancer and the clinical significance. Shinichiro Kase, Kenji Sugio, Koji Yamazaki, PubMed Tumor BiologyLung Cancer TissuesOncologyTissue IntegrityMalignant Disease	2000	199
Nuclear expression of the Y-box binding protein, YB-1, as a novel marker of disease progression in non-small cell lung cancer. Kotaro Shibahara, Kenji Sugio, T Osaki, PubMed Inverted Ccaat BoxDisease ProgressionPathologyCancer BiologyTumor Biology	2001	174
K-ras mutations are a relatively late event in the pathogenesis of lung carcinomas Kenji Sugio, Yosuke Kishimoto, Arvind K. Virmani, Lung Cancer OncologyOncogenic AgentMedicinePathologyBronchial Neoplasm	1995	168
ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis. Kenji Sugio, Tatsuhiro Ishida, Hideki Yokoyama, PubMed Ras Gene MutationsOncogenic AgentHuman LungGeneticsEarly Stage Adenocarcinoma	1992	167
Association Between Estrogen Receptor-β Expression and Epidermal Growth Factor Receptor Mutation in the Postoperative Prognosis of Adenocarcinoma of the Lung Naohiro Nose, Kenji Sugio, Tsunehiro Oyama, Journal of Clinical Oncology	2008	162
Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile. I I Wistuba, Kenji Sugio, Jaclyn Y. Hung, PubMed Gallbladder CarcinomaRas Gene MutationsAllelic VariantMedicineGenetics	1995	158
Acquired resistance to gefitinib: The contribution of mechanisms other than the T790M, MET, and HGF status Takamitsu Onitsuka, Hidetaka Uramoto, Naohiro Nose, Lung Cancer Hgf StatusImmunologyFibroblast Growth FactorMedicineCell Biology	2009	151

Page 1